Gene · 2000
ELF4: E74 like ETS transcription factor 4
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ELF4: E74 like ETS transcription factor 4. Genes, record 2000. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2000
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q99607 | ETS-related transcription factor Elf-4 | 663 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents27
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44633 | Q99607 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44634 | Q99607 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4745 | Q99607 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14925 | Q99607 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4745 | Q99607 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14925 | Q99607 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 14925 | Q99607 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14764 | Q99607 | Espacenet |
| JP 2023554441 A | 2023-12-27 | 39 | Q99607 | Espacenet |
| KR 1020230128488 A | 2023-09-05 | 18 | Q99607 | Espacenet |
1 to 10 of 27
See all 27 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,476
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ELF4 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 5 | 2025 |
| U19AI089992 | Immune signatures of vaccine responses in vulnerable populations | 5 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 3 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 2 | 2025 |
| P30AI050410 | The University of North Carolina Center for AIDS Research | 2 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 2 | 2025 |
1 to 10 of 1,476Source NIH's project files
See all 1,476 nih grantsPapers1,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic evaluation of an EF1α RT-qPCR assay for RNA quality control in IPNV detection. | J Virol Methods | 2027 | 42764132 | PubTator, text mining | PubMed |
| A truncating ELF4 variant in a pediatric patient with autoinflammatory disease and cell type-specific immune alterations. | Front Immunol | 2026 | 42769205 | PubTator, text mining | PubMed |
| Genomic insights of invasive M1UK Group A Streptococci in Greece, 2019-2024. | Infect Genet Evol | 2026 | 42759865 | PubTator, text mining | PubMed |
| Quercetin Restores Antiviral Innate Immunity by Blocking BVDV Npro-Hsp70-Mediated ELF4 Degradation. | J Agric Food Chem | 2026 | 42554809 | PubTator, text mining | PubMed |
| Gram-positive oral bacteria as reservoirs of transferable antimicrobial resistance genes in dentistry. | J Conserv Dent Endod | 2026 | 42549467 | PubTator, text mining | PubMed |
Integrative multi-omics and single-cell analysis identifies EGFR pathway activation and metabolic reprogramming as potential synthetic lethal vulnerabilities in resistance to the FGFR inhibitor AZD4547. | J Transl Med | 2026 | 42351126 | PubTator, text mining | PubMed |
| Early-life carriage and antibiotic resistance of Streptococcus pneumoniae in infants from Sierra Leone. | Front Microbiol | 2026 | 42254515 | PubTator, text mining | PubMed |
| A novel ELF4 gene variant disrupts T and NK cell function in a patient with immune thrombocytopenia (ITP). | Inflamm Res | 2026 | 42151449 | PubTator, text mining | PubMed |
| Genomic and phenotypic characterization of a multidrug-resistant Streptococcus pneumoniae 19 F ST320 isolate from a pediatric SARS-CoV-2 case in Yogyakarta, Indonesia. | Sci Rep | 2026 | 42031823 | PubTator, text mining | PubMed |
| Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches. | Molecules | 2026 | 41976154 | PubTator, text mining | PubMed |
1 to 10 of 1,590
See all 1,590 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2000
GET https://conductscience.org/api/genes/v1/2000/patents?page=2